Learn how CYP3A4 and P‑gp affect antiviral drugs, key interaction partners, clinical risks, and step‑by‑step management strategies for safer therapy.
Learn how CYP3A4 and P‑gp affect antiviral drugs, key interaction partners, clinical risks, and step‑by‑step management strategies for safer therapy.
